Altre lingue BetterLife Pharma Inc. Canadian Securities Exchange

Azioni

BETR

CA08772P2026

Mercato chiuso - Canadian Securities Exchange Altri mercati azionari 16:50:44 15/05/2024			Variaz. 5gg	Var. 1 gen.
0,125 ^CAD	0,00%		-3,85%	+108,33%

14/05	BetterLife ottiene eccellenti dati di sicurezza cardiopolmonare animale per BETR-001 orale	CI
01/05	BetterLife Pharma avanza negli studi di abilitazione IND per BETR-001	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001	14/05
BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001	14/05
BetterLife Announces Intent to Complete Private Placement of Units	04/05
BetterLife Announces Intent to Complete Private Placement of Units	04/05
BetterLife Pharma Inc. announced that it expects to receive CAD 0.5 million in funding	03/05
BetterLife Pharma Advances IND-enabling Studies For BETR-001	01/05
BetterLife Advances BETR-001 IND-enabling Studies	01/05
BetterLife Advances BETR-001 IND-enabling Studies	01/05
BetterLife Pharma Inc. Advances BETR-001 IND-Enabling Studies	01/05
BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	15/04
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	11/04
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	11/04
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	03/04
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	03/04
BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding	03/04
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	04/03
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	04/03
BetterLife Pharma Inc. announced that it expects to receive CAD 0.1 million in funding	04/03
BetterLife Pharma Inc. announced that it has received CAD 0.065 million in funding	04/03
BetterLife Closes Convertible Debentures For Further Development of BETR-001	02/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BetterLife Pharma Inc. Canadian Securities Exchange

Azioni

BETR

CA08772P2026

Altre lingue

Filtri